Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA-seq03:21

RNA-seq

12.3K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
12.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dordaviprone Maintenance After Allogeneic HCT for High-Risk Acute Myeloid Leukemia and Myelodysplastic Neoplasm.

American journal of hematology·2026
Same author

Machine learning-driven QSAR modeling combined with single cell transcriptomics identifies novel drug targets for lung cancer.

Journal of translational medicine·2026
Same author

Heroin addiction modulates transcription factor binding in regulatory regions of the human putamen.

Scientific reports·2026
Same author

Real-time diagnosis of adult T-cell leukemia/lymphoma using HBZ RNA in situ hybridization.

American journal of clinical pathology·2026
Same author

Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotype.

The Journal of experimental medicine·2026
Same author

Transcriptomic signatures in tetrapartite brain region identifies shared and unique gene signatures for substance-use.

Frontiers in cellular neuroscience·2026

Related Experiment Video

Updated: Mar 3, 2026

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
11:52

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

11.0K

ChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-Seq data.

You Li1,2,3, Tayla B Heavican4, Neetha N Vellichirammal1

  • 1Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Nucleic Acids Research
|May 5, 2017
PubMed
Summary

ChimeRScope, an alignment-free method, accurately identifies chimeric fusion transcripts using RNA-Seq data. This novel tool outperforms existing methods and discovers new oncogenic transcripts, improving cancer diagnosis and treatment strategies.

More Related Videos

Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data
07:35

Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data

Published on: December 1, 2023

1.2K
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

10.1K

Related Experiment Videos

Last Updated: Mar 3, 2026

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
11:52

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

11.0K
Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data
07:35

Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data

Published on: December 1, 2023

1.2K
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

10.1K

Area of Science:

  • Genomics
  • Transcriptomics
  • Bioinformatics

Background:

  • RNA-sequencing (RNA-Seq) enables gene expression quantification and novel transcript discovery, including chimeric fusion transcripts.
  • Fusion transcripts are crucial biomarkers for cancer diagnosis, prognosis, and targeted therapy development.
  • Current fusion transcript detection relies on alignment-based software, which struggles with genomic alterations in cancer genomes, limiting accuracy.

Purpose of the Study:

  • To develop a novel, alignment-free method for accurate fusion transcript detection.
  • To overcome the limitations of alignment-based methods in complex cancer genomes.
  • To identify novel fusion transcripts with potential oncogenic functions.

Main Methods:

  • Developed ChimeRScope, an alignment-free tool utilizing gene "fingerprints" (k-mers) from RNA-Seq paired-end reads.
  • Applied ChimeRScope to published and in-house cancer datasets.
  • Validated findings through experimental methods.

Main Results:

  • ChimeRScope demonstrated superior performance compared to existing methods across various datasets, read lengths, and sequencing depths.
  • The tool successfully identified novel fusion transcripts with potential oncogenic roles in in-house datasets.
  • Experimental validation confirmed the accuracy and utility of ChimeRScope.

Conclusions:

  • ChimeRScope offers a robust and accurate alignment-free approach for fusion transcript detection.
  • The method enhances the identification of clinically relevant fusion transcripts, including novel ones.
  • ChimeRScope is a valuable tool for advancing cancer research and personalized medicine.